Holen Sie sich die Stockscreener-App
50.21
3.33%
1.62
Handel nachbörslich:
50.21
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Mirum Pharmaceuticals president sells $126,680 in stock By Investing.com - Investing.com Canada
Golden State Equity Partners Buys 18,080 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat
Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) PT at $57.10 - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year HighShould You Buy? - MarketBeat
Mirum Pharmaceuticals stock soars to all-time high of $49.59 - MSN
Mirum Pharmaceuticals stock soars to all-time high of $49.59 By Investing.com - Investing.com Canada
Recent Price Trend in Mirum Pharmaceuticals (MIRM) is Your Friend, Here's Why - Yahoo Finance
Mirum Pharmaceuticals stock soars to all-time high of $48.94 - MSN
Mirum Pharmaceuticals SVP sells shares worth $43,227 By Investing.com - Investing.com Australia
Insider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells 902 Shares of Stock - MarketBeat
Christopher Peetz Sells 6,837 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock - MarketBeat
Mirum Pharmaceuticals CEO sells shares worth $327,658 By Investing.com - Investing.com Australia
Mirum Pharmaceuticals SVP sells shares worth $43,227 - Investing.com India
Mirum Pharmaceuticals CEO sells shares worth $327,658 - Investing.com India
Mirum Pharmaceuticals president sells $152,256 in stock By Investing.com - Investing.com Canada
(MIRM) Long Term Investment Analysis - Stock Traders Daily
Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock? - MSN
FY2024 EPS Estimates for MIRM Increased by Leerink Partnrs - MarketBeat
Leerink Partnrs Issues Optimistic Estimate for MIRM Earnings - Defense World
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 12-Month HighShould You Buy? - MarketBeat
As Biotech Trade Gets Wonky, I'm Eyeing Two Clinical-Stage Companies - RealMoney
Cantor Fitzgerald Comments on MIRM FY2025 Earnings - Defense World
Mirum Pharmaceuticals stock soars to all-time high of $48.94 By Investing.com - Investing.com South Africa
Brokers Issue Forecasts for MIRM FY2025 Earnings - MarketBeat
Mirum Pharmaceuticals' chief medical officer sells $319,598 in stock By Investing.com - Investing.com Australia
Joanne Quan Sells 6,969 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock - MarketBeat
Biliary Atresia Market to Expand Significantly by 2034, States DelveInsight Report | Albireo Pharma, Mirum Pharmaceuticals - Barchart
Mirum Pharmaceuticals' chief medical officer sells $319,598 in stock - MSN
Financial Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) & Eyenovia (NASDAQ:EYEN) - Defense World
MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results - MSN
(MIRM) Investment Report - Stock Traders Daily
Hennion & Walsh Asset Management Inc. Purchases 29,545 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat
Mirum Pharmaceuticals (MIRM) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
Metagenomi Announces New Appointment to its Board of Directors - The Manila Times
Exploring Three High Growth Tech Stocks in the United States - Simply Wall St
Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price Up 6%Here's What Happened - MarketBeat
Mirum Pharmaceuticals exceeds 2024 sales forecast, eyes growth By Investing.com - Investing.com Australia
4.02%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):